U

investors

With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.

We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.

The Share

See More

Press Releases

2026

Sedana Medical announces PDUFA target action date for its New Drug Application in the U.S.
2026-08-31 07:30
Regulatory
Sedana Medical AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has set April 16, 2027 as the target action date under the Prescription...
Sedana Medical announces FDA acceptance for review of its New Drug Application in the U.S.
2026-08-19 07:30
Sedana Medical AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's New Drug Application...
Sedana Medical AB’s Interim report January-June 2026
2026-07-17 07:00
Regulatory MAR
NDA submission and improved EBITDA Second quarter 2026 January-June 2026 CEO comments NDA submission and improved EBITDA We submitted our New Drug Application...
View All Press Releases

Financial Reports

See More

Financial Calendar

See More

Latest Presentation

No presentations found.

See More